Literature DB >> 10950974

Manifestation of thrombocytopenia in dengue-2-virus-infected mice.

Kao-Jean Huang1, Shu-Yi J Li1, Shiour-Ching Chen1, Hsiao-Sheng Liu1, Yee-Shin Lin1, Trai-Ming Yeh1, Ching-Chuan Liu1, Huan-Yao Lei1.   

Abstract

Dengue virus infection causes dengue fever, dengue haemorrhagic fever and dengue shock syndrome. No animal model is available that mimics these clinical manifestations. In this study, the establishment is reported of a murine model for dengue virus infection that resembles the thrombocytopenia manifestation. Dengue-2 virus (dengue virus type 2) can infect murine cells either in vitro (primary cell culture) or in vivo. Viraemia detected by RT-PCR was found transiently at 2 days after intravenous injection of dengue-2 virus. Transient thrombocytopenia developed at 10-13 days after primary or secondary infection. Anti-platelet antibody was generated after dengue-2 virus infection. There was strain variation in dengue-2 virus infection; the A/J strain was more sensitive than BALB/c or B6 mice. This dengue-2-virus-infected mouse system accompanied by thrombocytopenia and anti-platelet antibody will be a valuable model to study the pathogenicity of dengue virus infection.

Entities:  

Mesh:

Year:  2000        PMID: 10950974     DOI: 10.1099/0022-1317-81-9-2177

Source DB:  PubMed          Journal:  J Gen Virol        ISSN: 0022-1317            Impact factor:   3.891


  42 in total

Review 1.  Recent advances in deciphering viral and host determinants of dengue virus replication and pathogenesis.

Authors:  Karen Clyde; Jennifer L Kyle; Eva Harris
Journal:  J Virol       Date:  2006-08-23       Impact factor: 5.103

Review 2.  Immunity to dengue virus: a tale of original antigenic sin and tropical cytokine storms.

Authors:  Alan L Rothman
Journal:  Nat Rev Immunol       Date:  2011-07-15       Impact factor: 53.106

3.  Productive dengue virus infection of human endothelial cells is directed by heparan sulfate-containing proteoglycan receptors.

Authors:  Nadine Dalrymple; Erich R Mackow
Journal:  J Virol       Date:  2011-07-06       Impact factor: 5.103

Review 4.  An Overview of Animal Models for Arthropod-Borne Viruses.

Authors:  Erin S Reynolds; Charles E Hart; Meghan E Hermance; Douglas L Brining; Saravanan Thangamani
Journal:  Comp Med       Date:  2017-06-01       Impact factor: 0.982

5.  Castanospermine, a potent inhibitor of dengue virus infection in vitro and in vivo.

Authors:  Kevin Whitby; Theodore C Pierson; Brian Geiss; Kelly Lane; Michael Engle; Yi Zhou; Robert W Doms; Michael S Diamond
Journal:  J Virol       Date:  2005-07       Impact factor: 5.103

6.  In vivo infection by a neuroinvasive neurovirulent dengue virus.

Authors:  Myriam Lucia Velandia-Romero; Orlando Acosta-Losada; Jaime E Castellanos
Journal:  J Neurovirol       Date:  2012-07-24       Impact factor: 2.643

7.  A mouse-passaged dengue virus strain with reduced affinity for heparan sulfate causes severe disease in mice by establishing increased systemic viral loads.

Authors:  Tyler R Prestwood; Daniil M Prigozhin; Kristin L Sharar; Raphaël M Zellweger; Sujan Shresta
Journal:  J Virol       Date:  2008-06-18       Impact factor: 5.103

8.  Gammaherpesvirus latency induces antibody-associated thrombocytopenia in mice.

Authors:  Michael L Freeman; Claire E Burkum; Kathleen G Lanzer; Alan D Roberts; Mykola Pinkevych; Asako Itakura; Lawrence W Kummer; Frank M Szaba; Miles P Davenport; Owen J T McCarty; David L Woodland; Stephen T Smiley; Marcia A Blackman
Journal:  J Autoimmun       Date:  2012-12-14       Impact factor: 7.094

9.  Indoor-breeding of Aedes albopictus in northern peninsular Malaysia and its potential epidemiological implications.

Authors:  Hamady Dieng; Rahman G M Saifur; Ahmad Abu Hassan; M R Che Salmah; Michael Boots; Tomomitsu Satho; Zairi Jaal; Sazaly AbuBakar
Journal:  PLoS One       Date:  2010-07-27       Impact factor: 3.240

10.  Dengue virus NS1 enhances viral replication and pro-inflammatory cytokine production in human dendritic cells.

Authors:  Farah Alayli; Frank Scholle
Journal:  Virology       Date:  2016-06-24       Impact factor: 3.616

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.